Request to Revise AB 609 to Include Puberty Blockers for Transgender Youth

The exclusion of puberty blockers for transgender youth in AB 609 contradicts its stated aim of protecting the physician-patient relationship. This exclusion, coupled with the lack of support from any Democrats, raises concerns about the bill's true intentions. It is crucial to ensure that all individuals, regardless of their gender identity, have access to necessary medical treatments. Therefore, it is requested that the bill be revised to include puberty blockers for transgender youth. This would align with the bill's original intent of promoting medical freedom and would demonstrate a commitment to the health and well-being of all constituents.